What medications can help with anxiety in a patient with Bipolar II disorder, currently taking lamictal (lamotrigine) 200mg and abilify (aripiprazole) 2mg?

Anxiety Management in Bipolar II Disorder on Lamotrigine and Aripiprazole

Direct Recommendation

Add buspirone 5mg twice daily (titrating to maximum 20mg three times daily) as the first-line anxiolytic for this patient, as it provides effective anxiety relief without risking mood destabilization, tolerance, or dependence that occurs with benzodiazepines. 1, 2

---

Evidence-Based Rationale

Why Buspirone is Optimal for This Patient

• Buspirone is a non-benzodiazepine anxiolytic specifically recommended for anxiety management in bipolar disorder patients already on mood stabilizers like lamotrigine 2
• Unlike benzodiazepines, buspirone does not cause tolerance, addiction, depression, or cognitive impairment with regular use 2
• Buspirone avoids the 10% risk of paradoxical agitation seen with benzodiazepines 2
• The patient's current regimen (lamotrigine 200mg + aripiprazole 2mg) provides mood stabilization, allowing safe addition of buspirone without risking mood destabilization 1, 2

Lamotrigine's Role in This Regimen

• Lamotrigine is FDA-approved for maintenance therapy in bipolar disorder and is particularly effective for preventing depressive episodes, which dominate the clinical picture of bipolar disorder 1, 3, 4
• Lamotrigine significantly delays time to intervention for any mood episode compared to placebo in bipolar I disorder 1, 3
• The current 200mg dose is appropriate for maintenance therapy 1

Aripiprazole's Contribution

• Aripiprazole is a first-line atypical antipsychotic for bipolar disorder with a favorable metabolic profile compared to alternatives like olanzapine 1, 5
• The 2mg dose is relatively low but may provide adequate mood stabilization when combined with lamotrigine 1

---

Practical Implementation Algorithm

Starting Buspirone

1. Initial dose: Begin buspirone 5mg twice daily 2
2. Titration: Increase by 5mg increments every 3-4 days as tolerated 2
3. Target dose: 15-20mg twice daily (maximum 20mg three times daily) 2
4. Timeline: Full anxiolytic effects require 2-4 weeks to develop 1

Alternative Pharmacological Options if Buspirone Fails

• Quetiapine: Has anxiolytic properties and is FDA-approved for bipolar disorder, with sedative effects beneficial for anxiety and sleep disturbances 2, 5, 6
• Valproate: Functions as both mood stabilizer and anxiolytic, with initial dosing of 125mg twice daily titrated to therapeutic levels of 40-90 mcg/mL 2
• SSRIs (sertraline or escitalopram): Can be added cautiously in combination with existing mood stabilizers, but require close monitoring for mood destabilization and treatment-emergent mania 1, 7

---

Critical Medications to Avoid

Benzodiazepines (Lorazepam, Clonazepam, Alprazolam)

• Regular benzodiazepine use leads to tolerance, addiction, depression, and cognitive impairment 2
• Approximately 10% of patients experience paradoxical agitation 2
• If benzodiazepines are absolutely necessary for acute anxiety, use infrequent, low doses of short-acting agents (lorazepam 0.25-0.5mg PRN, maximum 2-3 times weekly) 1
• Benzodiazepines should be time-limited to days or weeks, not ongoing daily use 1

Antidepressant Monotherapy

• Never use antidepressants without mood stabilizers in bipolar disorder, as this triggers manic episodes, mood destabilization, and rapid cycling 1, 5
• If adding an SSRI for comorbid anxiety/depression, always maintain lamotrigine and aripiprazole 1, 7

---

Adjunctive Non-Pharmacological Interventions

• Cognitive-behavioral therapy (CBT): Has strong evidence for treating both anxiety and depression components of bipolar disorder 1, 2
• Psychoeducation: Should accompany all pharmacotherapy regarding symptoms, course of illness, treatment options, and medication adherence 1
• Combined treatment (CBT + medication): Superior to either treatment alone for anxiety disorders 1, 7

---

Monitoring Requirements

Initial Phase (First 4-8 Weeks)

• Assess anxiety symptoms weekly using standardized measures (GAD-7) 1
• Monitor for mood destabilization, emergence of manic/hypomanic symptoms, or worsening depression 1, 2
• Evaluate medication adherence and side effects 1

Maintenance Phase

• Continue monitoring monthly once stable 1
• Maintain lamotrigine and aripiprazole for at least 12-24 months after mood stabilization 1, 5
• Some patients require lifelong maintenance therapy 1

---

Common Pitfalls to Avoid

• Prescribing daily benzodiazepines: Creates dependence and worsens long-term outcomes despite short-term relief 1, 2
• Adding antidepressants without mood stabilizers: Triggers mania in 15-20% of bipolar patients 1, 5
• Discontinuing effective mood stabilizers prematurely: Over 90% of noncompliant patients relapse versus 37.5% of compliant patients 1
• Expecting immediate buspirone effects: Full anxiolytic response requires 2-4 weeks, unlike benzodiazepines which work immediately 1
• Overlooking psychotherapy: Medication alone is insufficient; combined treatment with CBT produces superior outcomes 1, 2, 7

---

Expected Timeline for Response

• Buspirone: Initial response at 2-4 weeks, maximal benefit by 6-8 weeks 1
• If inadequate response at 8 weeks: Consider increasing buspirone to maximum dose, adding quetiapine, or cautiously adding an SSRI with close monitoring 1, 2
• If severe anxiety persists: Reassess diagnosis for comorbid anxiety disorders (GAD, panic disorder, PTSD) requiring specialized treatment 1, 7